These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8648115

  • 1. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C.
    J Immunol; 1996 Jun 15; 156(12):4697-706. PubMed ID: 8648115
    [Abstract] [Full Text] [Related]

  • 2. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
    Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C.
    J Virol; 2001 Aug 15; 75(16):7330-8. PubMed ID: 11462005
    [Abstract] [Full Text] [Related]

  • 3. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
    Fayolle C, Ladant D, Karimova G, Ullmann A, Leclerc C.
    J Immunol; 1999 Apr 01; 162(7):4157-62. PubMed ID: 10201941
    [Abstract] [Full Text] [Related]

  • 4. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
    Préville X, Ladant D, Timmerman B, Leclerc C.
    Cancer Res; 2005 Jan 15; 65(2):641-9. PubMed ID: 15695409
    [Abstract] [Full Text] [Related]

  • 5. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
    Saron MF, Fayolle C, Sebo P, Ladant D, Ullmann A, Leclerc C.
    Proc Natl Acad Sci U S A; 1997 Apr 01; 94(7):3314-9. PubMed ID: 9096390
    [Abstract] [Full Text] [Related]

  • 6. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S, Kamanova J, Simsova M, Sebo P, Bolte S, Heussler V, Fleischer B, Jacobs T.
    Infect Immun; 2006 Apr 01; 74(4):2277-85. PubMed ID: 16552058
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
    Bachmann MF, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, Ricciardi-Castagnoli P.
    Eur J Immunol; 1996 Nov 01; 26(11):2595-600. PubMed ID: 8921944
    [Abstract] [Full Text] [Related]

  • 8. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.
    J Immunol; 1998 Nov 01; 161(9):5087-96. PubMed ID: 9794447
    [Abstract] [Full Text] [Related]

  • 9. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C, Bauche C, Ladant D, Leclerc C.
    Vaccine; 2004 Dec 16; 23(5):604-14. PubMed ID: 15542180
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B, Steimer KS, Walker CM.
    Eur J Immunol; 1994 Oct 16; 24(10):2369-76. PubMed ID: 7523139
    [Abstract] [Full Text] [Related]

  • 12. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 13. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 01; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J, Grusby MJ, Schirmbeck R, Reimann J.
    J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922
    [Abstract] [Full Text] [Related]

  • 17. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA, Ahmed R, Oldstone MB.
    J Immunol; 1984 Jul 15; 133(1):433-9. PubMed ID: 6202788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.